UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 11/2019, Volume 74, Issue 11, pp. 3402 - 3403
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 12, pp. 1812 - 1819
HIV/AIDS | Hepatitis | Antiretrovirals | HIV | Hepatitis antigens | Vaccination | Viruses | Infections | Hepatitis B virus | Art periods | Genotypes | resistant | tenofovir disoproxil fumarate | chronic infection | lamivudine | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Drug Resistance, Viral | Hepatitis B - virology | Male | Alanine Transaminase - blood | Antibiotic Prophylaxis | Hepatitis B - blood | Hepatitis B Surface Antigens - blood | Tenofovir | Hepatitis B - immunology | Hepatitis B Antibodies - blood | Adenine - therapeutic use | Lamivudine - therapeutic use | Adult | Female | Retrospective Studies | HIV Infections - blood | Hepatitis B Core Antigens - blood | Anti-Retroviral Agents - therapeutic use | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | HIV Infections - virology | Kaplan-Meier Estimate | Hepatitis B Surface Antigens - immunology | Hepatitis B Core Antigens - immunology | HIV Infections - drug therapy | Hepatitis B - prevention & control | Hepatitis B Antibodies - immunology | Complications and side effects | Highly active antiretroviral therapy | Patient outcomes | Drug therapy | HIV infection | Health aspects | Risk factors | Hepatitis B | Antiretroviral drugs | Antigens | Genotype & phenotype | Drug resistance | Viral infections | Index Medicus
Journal Article
Nature immunology, ISSN 1529-2908, 07/2019, Volume 20, Issue 7, pp. 824 - 834
Life Sciences & Biomedicine | Immunology | Science & Technology | HIV-1 | Prognosis | Humans | Receptors, CCR5 - genetics | RNA, Messenger - metabolism | Viral Load | CD4-Positive T-Lymphocytes - immunology | Genetic Variation | Receptors, CCR5 - metabolism | Cell Membrane - metabolism | 3' Untranslated Regions | CD4-Positive T-Lymphocytes - virology | Genes, Reporter | HIV Infections - genetics | HIV Infections - virology | RNA, Messenger - genetics | CD4-Positive T-Lymphocytes - metabolism | Gene Expression Regulation | Population Groups - genetics | Genotype | RNA, Long Noncoding - genetics | RNA Stability | Linkage Disequilibrium | Alleles | Biomarkers | Polymorphism, Single Nucleotide | HIV Infections - metabolism | RNA, Antisense - genetics | Medical research | Genes | Genomics | Development and progression | Antisense RNA | Genomes | Genetic transcription | T cells | HIV (Viruses) | Genetic polymorphisms | Infection | Messenger RNA | Medicine, Experimental | Genetic research | Genetic aspects | Health aspects | HIV infection | Protein binding | Genome-wide association studies | Care and treatment | Genetic variation | Analysis | Research | Single nucleotide polymorphisms | CCR5 protein | Viruses | Infections | mRNA | Lymphocytes T | Gene expression | Ribonucleic acid--RNA | CD4 antigen | RNA-binding protein | Lymphocytes | Human immunodeficiency virus--HIV | Activating transcription factor 1 | Binding sites | Genetic variance | 3' Untranslated regions | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 11/2020, Volume 10, Issue 1, pp. 19416 - 19416
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Plasma | CCR5 protein | Nef protein | Viremia | Lymphocytes | Infectivity | Human immunodeficiency virus--HIV | Histocompatibility antigen HLA | Mutation | Immunity (cell-mediated) | CXCR4 protein | CD4 antigen | Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 06/2017, Volume 215, Issue 12, pp. 1893 - 1897
HIV | bone quality | integrase strand transfer inhibitor (INSTI) | osteoblast differentiation | protease inhibitor (PI) | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Lysine - analogs & derivatives | HIV-1 - drug effects | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Biomarkers - blood | Arginine - analogs & derivatives | Osteocalcin - blood | Bone Density - drug effects | Animals | Arginine - blood | Protease Inhibitors - adverse effects | Female | Integrase Inhibitors | Mice | Retrospective Studies | Reverse Transcriptase Inhibitors | Lysine - blood | Antiviral agents | Usage | Care and treatment | Fractures | Protease inhibitors | Bones | Research | HIV (Viruses) | Osteoblasts | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 2014, Volume 65, Issue 2, pp. 213 - 217
Illicit drug use | Incident HCV infection | Injection drug use | Asia | Tokyo | Men who have sex with men | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Homosexuality, Male | Hepatitis C - epidemiology | Humans | Risk Factors | Tokyo - epidemiology | HIV Infections - complications | Adult | Male | Urban Population | Substance-Related Disorders - complications | Incidence | Hepatitis | Injections | Human immunodeficiency virus--HIV | Men | Sexual behavior | Drug use | Risk factors | Index Medicus | AIDS/HIV | Acquired immune deficiency syndrome
Journal Article
Molecular therapy, ISSN 1525-0016, 04/2016, Volume 24, Issue 4, pp. 832 - 842
Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Adenoviruses, Simian - immunology | Humans | AIDS Vaccines - immunology | CD4 Lymphocyte Count | Vaccinia virus - immunology | Viral Load | HIV Infections - immunology | Animals | HIV-1 - physiology | HIV Infections - therapy | Mice | HeLa Cells | AIDS Vaccines - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Index Medicus | Original
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 7/2015, Volume 61, Issue 2, pp. 177 - 183
ARTICLES AND COMMENTARIES | amoxicillin | treatment | syphilis | HIV | MSM | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Syphilis - immunology | Administration, Oral | Humans | Risk Factors | Probenecid - administration & dosage | Male | Syphilis - prevention & control | Syphilis Serodiagnosis | Treatment Outcome | CD4 Lymphocyte Count | Young Adult | Probenecid - adverse effects | Syphilis - diagnosis | Amoxicillin - therapeutic use | HIV Infections - complications | Syphilis - drug therapy | Adult | Amoxicillin - adverse effects | Amoxicillin - administration & dosage | Retrospective Studies | Syphilis - complications | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Probenecid - therapeutic use | Dose-response relationship (Biochemistry) | Care and treatment | Syphilis | Amoxicillin | HIV patients | Dosage and administration | Health aspects | Risk factors | Probenecid | Confidence intervals | Antibiotics | Drug dosages | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 05/2016, Volume 72, Issue 1, pp. 11 - 14
Plasma concentrations | ATP-binding cassette transporter B1 | ATP-binding cassette transporter G2 | Antiretroviral therapy | Raltegravir | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Humans | Japan | Middle Aged | Raltegravir Potassium - therapeutic use | Male | ATP-Binding Cassette Transporters - genetics | HIV Integrase Inhibitors - therapeutic use | Polymorphism, Single Nucleotide - genetics | Raltegravir Potassium - blood | Female | HIV Infections - drug therapy | HIV Integrase Inhibitors - blood | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Neoplasm Proteins - genetics | ATP Binding Cassette Transporter, Sub-Family B - genetics | Genotype & phenotype | Plasma | ABC transporters | Biological variation | Genes | Polymorphism | Index Medicus | AIDS/HIV
Journal Article
Nature immunology, ISSN 1529-2908, 11/2019, Volume 20, Issue 11, pp. 1555 - 1555
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 11/2012, Volume 55, Issue 9, pp. 1262 - 1269
HIV/AIDS | Antiretrovirals | Body mass index | HIV | Protease inhibitors | Predisposing factors | AIDS | Uric acid | Hepatitis B virus | Kidney stones | Arts | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Infectious diseases | Urinary lithiasis | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV Protease Inhibitors - adverse effects | Kidney Calculi - chemically induced | Pyridines - administration & dosage | Ritonavir - administration & dosage | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | HIV Protease Inhibitors - administration & dosage | Oligopeptides - adverse effects | Incidence | Anti-HIV Agents - administration & dosage | Pyridines - adverse effects | Ritonavir - adverse effects | HIV Infections - complications | Atazanavir Sulfate | Adult | Female | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Retrospective Studies | Antiretroviral Therapy, Highly Active - methods | Cohort Studies | Complications and side effects | Demographic aspects | Distribution | Dosage and administration | Research | Drug therapy | HIV infection | Antiretroviral drugs | Human immunodeficiency virus--HIV | Multivariate analysis | Medical diagnosis | Patients | Index Medicus | All-terrain vehicles | proteinase inhibitors | Antiretroviral agents | Risk factors
Journal Article
Japanese journal of infectious diseases, ISSN 1344-6304, 2016, Volume 69, Issue 3, pp. 236 - 243
HIV-1 | enhanced neutralization | neutralizing antibody | M434I mutation | maraviroc resistant mutation | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | HIV Envelope Protein gp120 - genetics | Immunoglobulin G - isolation & purification | Immune Sera - chemistry | Antibodies, Viral - pharmacology | Antibodies, Monoclonal - biosynthesis | Cyclohexanes - pharmacology | Humans | Receptors, CCR5 - genetics | Neutralization Tests | Receptors, CCR5 - immunology | CD4-Positive T-Lymphocytes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Immunoglobulin G - biosynthesis | Immunoglobulin G - pharmacology | HIV Envelope Protein gp120 - chemistry | CD4-Positive T-Lymphocytes - virology | Antibodies, Viral - biosynthesis | Cell Line | Gene Expression | HIV-1 - drug effects | Antibodies, Monoclonal - pharmacology | HIV Infections - virology | Antibodies, Neutralizing - pharmacology | Antibodies, Monoclonal - isolation & purification | HIV Fusion Inhibitors - pharmacology | HIV-1 - genetics | Antibodies, Viral - isolation & purification | Antibodies, Neutralizing - isolation & purification | Triazoles - pharmacology | Drug Resistance, Viral - genetics | HIV-1 - immunology | Antibodies, Neutralizing - biosynthesis | Mutation | CD4-Positive T-Lymphocytes - drug effects | Index Medicus
Journal Article